Bioequivalence and Pharmacokinetics Study of Losartan Potassium Tablets in Healthy Volunteers by LC-MS/MS Method
Meng Wang
Abstract
Meng Wang
Abstract
OBJECTIVE To develope an LC-MS/MS method for the determination of losartan in human plasma,and to evaluate the pharmacokinetics and bioequivalence of losartan tablets in healthy volunteers.METHODS A single oral dose of reference and test tablets was given to 20 healthy male volunteers according to a randomized crossover design.Plasma concentrations were determined by LC-MS/MS after deproteinization by methanol.The pharmacokinetic parameters were calculated by DAS2.0.RESULTS The main pharmacokinetic parameters of losartan test and reference preparations were as follows: ρmax(222±131) and(226±166) μg·L-1,tmax(1.28±0.64) and(1.45±0.70) h,t1/2(1.91±0.32) and(1.90±0.37) h,AUC0-12 h(450±191) and(446±227) μg·h·L-1,respectively.The relative bioavailability of the test preparation was(104.0 ±14.3)%.CONCLUSION The LC-MS/MS method is proved to be accurate,sensitive and convenient;the test tablets are bioequivalent to the reference tablets.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To develope an LC-MS/MS method for the determination of losartan in human plasma,and to evaluate the pharmacokinetics and bioequivalence of losartan tablets in healthy volunteers.METHODS A single oral dose of reference and test tablets was given to 20 healthy male volunteers according to a randomized crossover design.Plasma concentrations were determined by LC-MS/MS after deproteinization by methanol.The pharmacokinetic parameters were calculated by DAS2.0.RESULTS The main pharmacokinetic parameters of losartan test and reference preparations were as follows: ρmax(222±131) and(226±166) μg·L-1,tmax(1.28±0.64) and(1.45±0.70) h,t1/2(1.91±0.32) and(1.90±0.37) h,AUC0-12 h(450±191) and(446±227) μg·h·L-1,respectively.The relative bioavailability of the test preparation was(104.0 ±14.3)%.CONCLUSION The LC-MS/MS method is proved to be accurate,sensitive and convenient;the test tablets are bioequivalent to the reference tablets.
Key concepts: Bioequivalence, Pharmacokinetics, Losartan Potassium, Bioavailability, Losartan, Crossover study, Chromatography, Pharmacology